Companion and Complementary Diagnostics–Focus on PD-L1 Expression Assays for PD-1/PD-L1 Checkpoint Inhibitors in Non–Small Cell Lung Cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Pharmacology
Reference29 articles.
1. Companion diagnostics—a tool to improve pharmacotherapy;Jørgensen;Ann Transl Med.,2016
2. The role of companion diagnostics in the development and use of mutation-targeted cancer therapies;Papadopoulos;Nat Biotechnol.,2006
3. Companion and complementary diagnostics—clinical and regulatory perspectives;Jørgensen;Trends Cancer,2016
4. Update on programmed death-1 and programmed death-ligand 1 inhibition in the treatment of advanced or metastatic non-small cell lung cancer;Iafolla;Front Oncol.,2017
5. Real-world treatment patterns for patients receiving second-line and third-line treatment for advanced non-small cell lung cancer: a systematic review of recently published studies;Davies;PLoS One,2017
Cited by 73 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The clinicopathological significance and prognostic value of PD‐L1 in oral squamous cell carcinoma;Oral Diseases;2024-08-02
2. Molecular insights into clinical trials for immune checkpoint inhibitors in colorectal cancer: Unravelling challenges and future directions;World Journal of Gastroenterology;2024-04-07
3. Immunohistochemical detection of cancer genetic abnormalities;Pathology - Research and Practice;2024-03
4. New immunotherapy approaches as the most effective treatment for uveal melanoma;Critical Reviews in Oncology/Hematology;2024-02
5. Image‐based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno‐oncology Biomarker Working Group on Breast Cancer;The Journal of Pathology;2024-01-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3